Since MYC has been reported to be a client of HSP90 in mantle cell lymphoma [13], and HSP90 inhibition caused protein destabilization of MYC and NMYC in neuroblastoma [14], we speculated that the MYC-HSP90 axis might also be critical in Burkitt lymphoma. The gene discussed is MYCN; the disease is mantle cell lymphoma.